Ultromics granted FDA Breakthrough Device Status
British company Ultromics has been granted FDA Breakthrough Device Status for its artificial intelligence (AI)-enhanced platform for detecting cardiac amyloidosis.EchoGo Amyloidosis uses AI technology to analyse echocardiograms to detect the presence of cardiac amyloidosis….
Continue Reading